Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Total Debt (2020)

Maxcyte (MXCT) has disclosed Total Debt for 1 consecutive years, with $4.9 million as the latest value for Q4 2020.

  • On a quarterly basis, Total Debt changed N/A to $4.9 million in Q4 2020 year-over-year; TTM through Dec 2020 was $4.9 million, a N/A change, with the full-year FY2020 number at $4.9 million, changed N/A from a year prior.
  • Total Debt was $4.9 million for Q4 2020 at Maxcyte.
  • In the past five years, Total Debt ranged from a high of $4.9 million in Q4 2020 to a low of $4.9 million in Q4 2020.